Comparative Effectiveness of Two Doses Versus Three Doses of Hepatitis A Vaccine in Kidney transplant recipients in Chulalongkorn hospital

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

TCTR

Registry ID

TCTR20180325001

Enrollment

400

Registered

2018-03-25

Start date

2016-07-01

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergy Hepatitis A Prevalence of hepatitis A Hepatitis A vaccine Three doses of hepatitis A vaccine Kidney transplant recipients

Interventions

Give extra dose of standard hepatitis A vaccine from 2 doses (0 and 6 months) to 3 doses (0&#44

1 and 6 months),Give standard dose of hepatitis A vaccine at 0 and 6 months

Active Comparator Biological/Vaccine,Active Comparator Biological/Vaccine

3 doses of Hepatitis A Vaccine in Kidney transplant recipients,2 doses of Hepatitis A Vaccine in Kidney transplant recipients

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Kidney transplant recipients who age over 18 year-old in Chulalongkorn hospital

Exclusion criteria

Exclusion criteria: Kidney transplant recipients who known allergy to hepatitis A vaccine

Design outcomes

Primary

Measure	Time frame
Comparative Effectiveness of 2 Versus 3 Doses of Hepatitis A Vaccine in Kidney transplant recipients 2 years Automated chemiluminescent micro particle immunoassay	—

Secondary

Measure	Time frame
Prevalence of seropositive for anti-HAV IgG in Kidney transplant recipients 1 year Automated chemiluminescent micro particle immunoassay	—

Countries

Thailand

Contacts

Public ContactThaninee Prasoppokakorn

Faculty of Medicine, Chulalongkorn university

thanineeeve@gmail.com0896639930

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Apr 4, 2026